These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 10672305)

  • 1. Experimental study of intracisternal administration of tissue-type plasminogen activator followed by cerebrospinal fluid drainage in the ultra-early stage of subarachnoid haemorrhage.
    Kawada S; Kinugasa K; Meguro T; Hirotsune N; Tokunaga K; Kamata I; Nakashima H; Ohmoto T
    Acta Neurochir (Wien); 1999; 141(12):1331-8. PubMed ID: 10672305
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vasospasm prevention with postoperative intrathecal thrombolytic therapy: a retrospective comparison of urokinase, tissue plasminogen activator, and cisternal drainage alone.
    Usui M; Saito N; Hoya K; Todo T
    Neurosurgery; 1994 Feb; 34(2):235-44; discussion 244-5. PubMed ID: 8177383
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevention of symptomatic vasospasm after aneurysmal subarachnoid hemorrhage by intraoperative cisternal fibrinolysis using tissue-type plasminogen activator combined with continuous cisternal drainage.
    Kinouchi H; Ogasawara K; Shimizu H; Mizoi K; Yoshimoto T
    Neurol Med Chir (Tokyo); 2004 Nov; 44(11):569-75; discussion 576-7. PubMed ID: 15686175
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of recombinant streptokinase on the development of chronic cerebral vasospasm after subarachnoid hemorrhage in a swine model.
    Xu H; Chen X; Qin Z; Gu Y; Zhou P
    Acta Neurochir (Wien); 2011 Jun; 153(6):1333-8; discussion 1338. PubMed ID: 21311917
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prospective study on the prevention of cerebral vasospasm by intrathecal fibrinolytic therapy with tissue-type plasminogen activator.
    Mizoi K; Yoshimoto T; Takahashi A; Fujiwara S; Koshu K; Sugawara T
    J Neurosurg; 1993 Mar; 78(3):430-7. PubMed ID: 8433145
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined cisternal drainage and intrathecal urokinase injection therapy for prevention of vasospasm in patients with aneurysmal subarachnoid hemorrhage.
    Moriyama E; Matsumoto Y; Meguro T; Kawada S; Mandai S; Gohda Y; Sakurai M
    Neurol Med Chir (Tokyo); 1995 Oct; 35(10):732-6. PubMed ID: 8532128
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intrathecal urokinase infusion through a microcatheter into the cisterna magna to prevent cerebral vasospasm: experimental study in dogs.
    Mizuno T; Hamada J; Kai Y; Todaka T; Morioka M; Ushio Y
    AJNR Am J Neuroradiol; 2003 Apr; 24(4):613-8. PubMed ID: 12695190
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of single intracisternal bolus injection of recombinant tissue plasminogen activator to prevent delayed cerebral vasospasm after experimental subarachnoid hemorrhage.
    Seifert V; Eisert WG; Stolke D; Goetz C
    Neurosurgery; 1989 Oct; 25(4):590-8. PubMed ID: 2507953
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phase I trial of tissue plasminogen activator for the prevention of vasospasm in patients with aneurysmal subarachnoid hemorrhage.
    Zabramski JM; Spetzler RF; Lee KS; Papadopoulos SM; Bovill E; Zimmerman RS; Bederson JB
    J Neurosurg; 1991 Aug; 75(2):189-96. PubMed ID: 1906534
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of adenovirus-mediated nitric oxide synthase gene transfer on vasospasm after experimental subarachnoid hemorrhage.
    Stoodley M; Weihl CC; Zhang ZD; Lin G; Johns LM; Kowalczuk A; Ghadge G; Roos RP; Macdonald RL
    Neurosurgery; 2000 May; 46(5):1193-202; discussion 1202-3. PubMed ID: 10807252
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effectiveness of combining continuous cerebrospinal drainage and intermittent intrathecal urokinase injection therapy in preventing symptomatic vasospasm following aneurysmal subarachnoid haemorrhage.
    Yamada K; Yoshimura S; Enomoto Y; Yamakawa H; Iwama T
    Br J Neurosurg; 2008 Oct; 22(5):649-53. PubMed ID: 18686067
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of poly(ADP-ribose) polymerase attenuates cerebral vasospasm after subarachnoid hemorrhage in rabbits.
    Satoh M; Date I; Nakajima M; Takahashi K; Iseda K; Tamiya T; Ohmoto T; Ninomiya Y; Asari S
    Stroke; 2001 Jan; 32(1):225-31. PubMed ID: 11136941
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early treatment of subarachnoid hemorrhage after preventing rerupture of an aneurysm.
    Kinugasa K; Kamata I; Hirotsune N; Tokunaga K; Sugiu K; Handa A; Nakashima H; Ohmoto T; Mandai S; Matsumoto Y
    J Neurosurg; 1995 Jul; 83(1):34-41. PubMed ID: 7782847
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of intrathecal administration of urokinase and tissue plasminogen activator on subarachnoid clot and chronic vasospasm in a primate model.
    Hariton GB; Findlay JM; Weir BK; Kasuya H; Grace MG; Mielke BW
    Neurosurgery; 1993 Oct; 33(4):691-6; discussion 696-7. PubMed ID: 8232810
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimal cerebrospinal fluid magnesium ion concentration for vasodilatory effect and duration after intracisternal injection of magnesium sulfate solution in a canine subarachnoid hemorrhage model.
    Mori K; Yamamoto T; Miyazaki M; Hara Y; Aiko Y; Koike N; Sakamoto S; Nakao Y; Esaki T
    J Neurosurg; 2011 Apr; 114(4):1168-75. PubMed ID: 21073257
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of intrathecally administered urokinase, tissue-type plasminogen activator, and combination of urokinase and lysine-plasminogen for clot lysis after experimental subarachnoid hemorrhage in dogs.
    Kajimoto Y; Ohta T; Kuroiwa T
    Neurosurgery; 1997 Mar; 40(3):572-7. PubMed ID: 9055298
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of Histological and Angiographic Measurements of the Basilar Artery in an Experimental Rabbit Subarachnoid Hemorrhage Model.
    Sahinoglu M; Karakoyun O; Alagoz F; Billur D; Aydin S; Akdag R; Akmangit I; Daglioglu E
    Turk Neurosurg; 2021; 31(2):254-260. PubMed ID: 33559871
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of intrathecal flunarizine and nimodipine treatments in cerebral vasospasm after experimental subarachnoid hemorrhage in rabbits.
    Civelek E; Solmaz I; Onal MB; Kircelli A; Temiz C; Secer HI; Izci Y; Gonul E
    Acta Neurochir Suppl; 2011; 110(Pt 2):69-73. PubMed ID: 21125448
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of low-dose tissue-plasminogen activator intracisternal administration for the prevention of cerebral vasospasm after subarachnoid hemorrhage.
    Yamamoto T; Esaki T; Nakao Y; Mori K
    World Neurosurg; 2010 Jun; 73(6):675-82. PubMed ID: 20934155
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of prophylactic intrathecal administrations of nicardipine on vasospasm in patients with severe aneurysmal subarachnoid haemorrhage.
    Shibuya M; Suzuki Y; Enomoto H; Okada T; Ogura K; Sugita K
    Acta Neurochir (Wien); 1994; 131(1-2):19-25. PubMed ID: 7709781
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.